GrantRover ↗

← Tüm fırsatlar

National Institutes of Health · ABD

Advanced Development and Validation of Emerging Technologies for Basic and… (R33 Clinical Trial Not Allowed)

Full title in the source: Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Ön duyuru — 15 Ocak 2027 tarihinde açılması bekleniyor

National Institutes of Health tarafından 14 hibe bekleniyor; proje başına $300.000’ye kadar; toplam bütçe $6,6 milyon. Bu bir ön duyurudur: fon sağlayıcı fırsatı duyurdu ancak henüz başvuruya açık değil; yayınlanması yaklaşık 15 Ocak 2027 tarihinde bekleniyor, tahmini son tarih 4 Haziran 2027. Uygun başvuru sahibi türleri (kaynakta): Private institutions of higher education, Native American tribal governments (Federally recognized), County governments ve 12 diğer.

Son başvuru
Tahmini 4 Haziran 2027 (henüz kesin değil)
Açılış
15 Ocak 2027
Hibe tutarı
Proje başına $300.000’ye kadar
Toplam bütçe
$6,6 milyon
Destek oranı
Zorunlu eş finansman belirtilmemiş; destek oranı belirtilmemiş
Toplam bütçe
$6,6 milyon
Beklenen hibe sayısı
14
Eş finansman
Gerekli değil
Olası başvuru sahipleri
Üniversiteler ve araştırma, Kamu kurumları, KOBİ’ler / girişimler, Şirketler, Kâr amacı gütmeyenler Kaynak kategorilerinden veya program kurallarından; uygunluğa çağrı karar verir.
Fon sağlayıcı
National Institutes of Health
Referans
RFA-CA-28-002
Destek listesi (ABD)
93.394 Cancer Detection and Diagnosis Research
Son kontrol
15 Kasım 2026

Resmi çağrıyı aç ↗

Resmi açıklamalar fon sağlayıcının dilindedir (çoğunlukla İngilizce); bu sayfadaki özet ve temel bilgiler Türkçedir.

Çağrı hakkında

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits grant applications proposing exploratory research projects focused on further development and validation of emerging technologies for cancer research or clinical care. This NOFO solicits R33 applications where major feasibility gaps for the technology or methodology have been overcome, as demonstrated with supportive preliminary data, but still requires further development, enhancements, optimizations, and rigorous technical validation to encourage adoption by the research community.

Well-suited applications must offer the potential to accelerate and/or enhance research in the areas of cancer biology, early detection and screening, clinical diagnosis, treatment, cancer control, and/or epidemiology. Projects that are in-scope include technologies with new or significantly improved technical capabilities to measure, analyze, model, or interrogate cancer-related systems. These may include, but are not limited to, advanced molecular and cellular analysis platforms, multi-omic and spatial profiling methods, imaging and sensing technologies, immuno-engineering approaches, and innovations in biospecimen processing, modeling, and quality assessment. Technologies proposed for development may have potential for widespread applicability but must be focused in this proposal on cancer applications. Projects proposing application of existing technologies where the novelty resides in the clinical target or biological question being pursued are not appropriate for this solicitation.

Tam metni oku

This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program.

Kimler başvurabilir

Başvuru sahibi kategorileri yalnızca bir başlangıç noktasıdır. Uygunluğa resmi çağrı karar verir.

Konular

Health

Nasıl başvurulur

  1. Read the full notice of funding opportunity (NOFO) linked from the official page: eligibility, cost sharing and evaluation criteria.
  2. Make sure your organisation has an active SAM.gov registration and Unique Entity ID (UEI); registration can take several weeks.
  3. For NIH: the organisation and the principal investigator also need eRA Commons accounts; applications are usually submitted through Grants.gov (for example with ASSIST).
  4. Prepare the required forms, narrative, budget and attachments exactly as the NOFO specifies.
  5. Submit before the deadline and keep the tracking number. Check for amendments before you submit.

From the call text

Who can apply
Not stated in the call text we hold — check the official page
Company stage
Not stated in the call text we hold — check the official page
Single applicant or consortium
Not stated in the call text we hold — check the official page
Where applicants must be based
Not stated in the call text we hold — check the official page
Where to apply
Not stated in the call text we hold — check the official page

İletişim

IMAT Program Contact · NCI-IMAT@nih.gov · 240-255-0917

Resmi kaynaklar

Resmi çağrı sayfası

Bu sayfadaki bilgiler resmi kaynaktan alınmıştır ve en son 15 Kasım 2026 tarihinde kontrol edilmiştir. Sonraki değişiklikler dahil, fon sağlayıcının kendi belgeleri her zaman önceliklidir.

National Institutes of Health: diğer çağrılar

National Institutes of Health ABD

Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High… (R34 Clinical Trial Required)

PAR-25-274

The goal of this notice of funding opportunity (NOFO) is to support feasibility trials of complementary and integrative health approaches with physical and/or psychologic…

National Institutes of Health ABD

Investigator Initiated Clinical Trials of Complementary and Integrative… (R01 Clinical Trial Required)

PAR-25-268

This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated fully remotely delivered and conducted clinical trials to assess the efficacy…

National Institutes of Health ABD

NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)

PAR-25-267

This notice of funding opportunity (NOFO) invites applications for investigator-initiated clinical trials of complementary and integrative health approaches with physical…

National Institutes of Health ABD

Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)

PAR-25-158

This Notice of Funding Opportunity (NOFO) focuses on prevention and intervention strategies for fetal alcohol spectrum disorders (FASD) throughout the lifespan. The inten…